Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Operating Expenses (2020 - 2025)

PROCEPT BioRobotics has reported Operating Expenses over the past 6 years, most recently at $77.4 million for Q4 2025.

  • Quarterly results put Operating Expenses at $77.4 million for Q4 2025, up 22.04% from a year ago — trailing twelve months through Dec 2025 was $300.1 million (up 28.4% YoY), and the annual figure for FY2025 was $300.1 million, up 28.4%.
  • Operating Expenses for Q4 2025 was $77.4 million at PROCEPT BioRobotics, roughly flat from $77.2 million in the prior quarter.
  • Over the last five years, Operating Expenses for PRCT hit a ceiling of $77.4 million in Q4 2025 and a floor of $14.9 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $44.3 million (2023), compared with a mean of $45.1 million.
  • Biggest five-year swings in Operating Expenses: soared 89.8% in 2022 and later rose 22.04% in 2025.
  • PROCEPT BioRobotics' Operating Expenses stood at $21.3 million in 2021, then soared by 67.31% to $35.7 million in 2022, then surged by 42.27% to $50.8 million in 2023, then rose by 24.74% to $63.4 million in 2024, then grew by 22.04% to $77.4 million in 2025.
  • The last three reported values for Operating Expenses were $77.4 million (Q4 2025), $77.2 million (Q3 2025), and $73.9 million (Q2 2025) per Business Quant data.